Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin, Metronidazole, and Chlorhexidine in Preventing Alveolar Osteitis
NCT07833176Not yet recruiting
- Sponsor
- Khyber Medical University
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Randomised, double-blind trial of amoxicillin and metronidazole in alveolar osteitis (AO) (3 arms), sponsored by Khyber Medical University. Primary endpoint: Incidence of Alveolar Osteitis at Day 7. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
amoxicillinmetronidazole
03
Conditions
alveolar osteitis (AO)
Beyond the preview
Go deeper on NCT07833176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07833176.